Abselion is a Cambridge University spin-out focused on transforming biomolecule quantification with fast, reliable, and accessible tools for protein and viral vector analysis. Its flagship platform, Amperia™, uses proprietary Redox Electrochemical Detection (RED) technology to deliver accurate, reproducible results — even from complex samples — without optics, fluidics, or specialist training. Designed for ease and speed at the bench, Abselion empowers scientists with high-quality insights across research and development workflows. Guided by the principle of precision made practical, the team brings together deep expertise in biology, assay development, and engineering.
The Amperia™ system combines compact hardware, assay-ready sensors, and integrated software to streamline protein quantification. Built to support scientists in discovery, development, and beyond, it delivers dependable data quickly and without unnecessary complexity — even from crude or complex samples.
The AAVX and AAV9 Total Capsid Quantification Kits extend the Amperia™ Protein Quantification System for streamlined measurement of adeno-associated virus (AAV) vectors. Incorporating CaptureSelect™ affinity reagents from Thermo Fisher Scientific, the kits provide robust, reproducible assays for both broad serotype coverage and AAV9-specific quantification.
The Protein A and Protein G Quantification Kits extend the Amperia™ Protein Quantification System for streamlined measurement of antibodies across subclasses and species. Using Fc capture with an inverse-occupancy format, the kits deliver reproducible titres directly from crude or clarified samples, with up to 320 tests per kit.
